Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
PR Newswire•13/08/2026•16:15 ET
0
Whiz Insights
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
SAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a clinical-stage medical therapeutic company, today announced financial results for fiscal first quarter ended June 30, 2026, and provided a corporate update.
Get started
Create a free account to read the full story.